Abstract:Infantile hemangioma (IH), the most common tumor of infancy, is characterized by an initial proliferation during infancy followed by spontaneous involution over the next 5-10 years, often leaving a fibro-fatty residuum. IH is traditionally considered a tumor of the microvasculature. However, recent data show the critical role of stem cells in the biology of IH with emerging evidence suggesting an embryonic developmental anomaly due to aberrant proliferation and differentiation of a hemogenic endothelium with a neural crest phenotype that possesses the capacity for endothelial, hematopoietic, mesenchymal, and neuronal differentiation. Current evidence suggests a putative placental chorionic mesenchymal core cell embolic origin of IH during the first trimester. This review outlines the emerging role of stem cells and their interplay with the cytokine niche that promotes a post-natal environment conducive for vasculogenesis involving VEGFR-2 and its ligand VEGF-A and the IGF-2 ligand in promoting cellular proliferation, and the TRAIL-OPG anti-apoptotic pathway in preventing cellular apoptosis in IH. The discovery of the role of the renin-angiotensin system in the biology of IH provides a plausible explanation for the programed biologic behavior and the β-blocker-induced accelerated involution of this enigmatic condition. This crucially involves the vasoactive peptide, angiotensin II, that promotes cellular proliferation in IH predominantly via its action on the ATIIR2 isoform. The role of the RAS in the biology of IH is further supported by the effect of captopril, an ACE inhibitor, in inducing accelerated involution of IH. The discovery of the critical role of RAS in IH represents a novel and fascinating paradigm shift in the understanding of human development, IH, and other tumors in general.

868 Hypoxia Induced Cyr61 Productions Involved in the Pathogenesis of Infantile Hemangioma

Using a pair of rectangular coils in the MOT for the production of cold atom clouds with large optical density.

Biology of Infantile Hemangioma

Signaling pathways in the development of infantile hemangioma

[Contribution to the genetic research on nosologic and nosographic problems in psychiatry. II].

CENPF May Act as a Novel Marker and Highlight the Influence of Pericyte in Infantile Hemangioma

Apolipoprotein A-I binding protein inhibits the formation of infantile hemangioma via cholesterol-regulated Hif1α activation

Cell Fate Regulation During the Development of Infantile Hemangioma

Targeting ESM1 via SOX4 promotes the progression of infantile hemangioma through the PI3K/AKT signaling pathway

Three-Dimensional Microtumor Formation of Infantile Hemangioma-Derived Endothelial Cells for Mechanistic Exploration and Drug Screening

Voltage and Frequency Controller for Isolated Asynchronous Generators Feeding 3-Phase 4-Wire Loads

Progress In The Treatment Of Infantile Hemangioma

CYR61 is Involved in Neonatal Hypoxic-ischemic Brain Damage Via Modulating Astrocyte-mediated Neuroinflammation

Mast cell in infantile hemangioma

Infantile hemangioma: the common and enigmatic vascular tumor

Characterization of epigenetic and transcriptional landscape in infantile hemangiomas with ATAC-seq and RNA-seq

Wheat flour lipids: III. structure of the mono- and digalactosylglycerol lipids

Expression of (pro)renin receptor and its effect on endothelial cell proliferation in infantile hemangioma

Management of infantile hemangiomas: Recent advances

ALKBH5 facilitates the progression of infantile hemangioma by increasing FOXF1 expression in a m6A-YTHDF2 dependent manner to activate HK-2 signaling

Transcriptional data analysis reveals the association between infantile hemangiomas and venous malformations